Consolidated Balance Sheets - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current Assets
Cash and cash equivalents	$ 21,600,899	$ 29,163,200
Restricted cash	5,007,531	5,004,789
Marketable securities	26,983,626	25,916,681
Accounts receivable, net of allowances of $0 at March 31, 2018 and December 31, 2017, respectively	144,256	234,461
Prepaid and other current assets	792,961	790,514
Total current assets	54,529,273	61,109,645
Property and equipment, net	178,109	256,905
Deferred tax assets	575,055	575,055
Other assets	1,434,077	1,434,077
Total assets	56,716,514	63,375,682
Current Liabilities
Accounts payable	866,840	1,343,089
Accrued liabilities	6,998,396	7,810,948
Notes payable, current	92,048	159,180
Total current liabilities	7,957,284	9,313,217
Other long-term liabilities	3,443,609	3,872,679
Total liabilities	11,400,893	13,185,896
Commitments and Contingencies
Stockholders' Equity
Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at March 31, 2018 and December 31, 2017, respectively	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 9,574,685 and 9,483,911 shares at March 31, 2018 and December 31, 2017, respectively	9,575	9,484
Additional paid-in capital	433,137,593	433,044,209
Treasury stock, at cost; 11,080 shares at March 31, 2018 and December 31, 2017, respectively	(707,637)	(707,637)
Accumulated deficit	(386,792,688)	(381,810,109)
Accumulated other comprehensive loss	(58,724)	(27,978)
Total Caladrius Biosciences, Inc. stockholders' equity	45,588,219	50,508,069
Noncontrolling interests	(272,598)	(318,283)
Total equity	45,315,621	50,189,786
Liabilities and Equity, Total	$ 56,716,514	$ 63,375,682

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.